Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial (Q33828580)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial |
scientific article |
Statements
Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial (English)
Stefan Suciu
Françoise Mazingue
Karima Yakouben
Geneviève Plat
Martine Munzer
Pierre Philippet
Carine Domenech
Anne Uyttebroeck
Nicolas Sirvent
Patrick Lutz
Dominique Plantaz
Frederic Millot
Nicole Dastugue
Sandrine Girard
Yves Benoit
Yves Bertrandfor
Children's Leukemia Group (CLG) of European Organisation for Research and Treatment of Cancer (EORTC)
Barbara De Moerloose
1 reference
1 reference
1 reference
1 reference